A sunny spring shines a glowing light on this drinks company's new chief
These all feel like positive steps for a company whose share price is no higher than it was 16 years ago. In the meantime, the balance sheet offers some downside protection and also the prospect for further progress. Net debt, adjusting for leases and a pension surplus, stands at €180m and a recent extension of banking facilities to 2030 means the management team has time on its side when it comes to effecting a turnaround in the company's fortunes. Free cash flow can serve to reduce those borrowings, and also fund cash returns to shareholders.
C&C increased its dividend by 5pc in the year just ended and also bought back €30m in stock, in keeping with the plan to return €150m in cash to shareholders across the financial years to February 2025, 2026 and 2027. That sum equates to a fifth of the current stock market capitalisation, using the exchange rate of €1.1934 to the pound that prevails at the time of writing.
Questor says: buy
Ticker: CCR
Share price: 162.8p
Update: Indivior
Such is the wild trajectory of the share price of Indivior since its demerger from the former Reckitt Benckiser 11 years ago that some investors may be relieved to see it cancel its secondary listing and withdraw from the London market. Others may feel the lowly valuation merits patient support even when the stock can only be traded on Nasdaq.
Sceptics will chunter about a history of litigation and profit warning, including three of the latter in 2024. Supporters will put forward Indivior's role as a developer of key treatments for substance abuse disorders, especially in the area of opioid dependency, and how 2024 saw the firm generate its highest levels of sales since 2014's spin-off and its best profits since 2017. Competition and how Presidential policy could affect Medicaid funding will be challenges and sources of further debate.
Both sides of the argument will then have to chew over the valuation. The shares stand well below their 2018 record highs of around £24. As a result, even after the final trading alert, which warned of lower sales in 2025 thanks to fall in revenues from Suboxone for which sales from Sublocade would not fully compensate, analysts' forecasts put the stock on a forward price-to-earnings ratio of less than nine times for 2025 and less than eight times for 2026. If Sublocade can still reach Indivior's medium-term target of $1.5bn, compared to the $756m recorded in 2024, then profits could motor and render the shares cheaper still.
Where the shares are listed will make no difference to this at all; new chief executive Joe Ciaffoni and new chair Dr. David Wheaton must get the company to deliver on its targets.
There is enough value here to persuade long-time holders to cling on.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
38 minutes ago
- Reuters
Prada CEO Gianfranco D'Attis to quit Italian luxury brand, WWD reports
June 22 (Reuters) - Prada (1913.F), opens new tab CEO Gianfranco D'Attis will leave the Italian luxury brand at the end of the month, fashion trade publication WWD reported on Sunday. It said the publication had learned D'Attis was leaving the group "by mutual agreement". Reuters could not immediately confirm the report.
Times
39 minutes ago
- Times
Trump tariffs leave UK firms scrambling to renegotiate contracts
British companies are looking to renegotiate supplier contracts as they scramble to find savings that can protect them from the impact of escalating US tariffs, according to new data. A survey of firms with more than 5,000 employees found that 90 per cent fear that President Trump's import duties would hurt their revenues and profits, with businesses looking at a series of ways to manage rising costs. More than half (55 per cent) said their main tool to deal with tariff threats was to review existing contracts to find savings or renegotiate better terms with break clauses that could account for the imposition of new levies, according to Acertis, which provides contract management software. Bernadette Bulacan at Icertis said companies' first resort 'to protect margins is to take a critical look at customer and supplier relationships. For many companies, the path to surviving tariff disruption starts not with policy lobbying but with a forensic look at what's already been committed to on paper.' She said firms were taking measures to include rules of termination and force majeure clauses in contracts to deal with costs caused by tariffs, while also seeking out new suppliers in countries that were not affected by sweeping US levies. The Trump administration applied a 90-day pause on reciprocal tariffs he had announced on most of the world economy on April 8, which is due to expire in early July. The president has signed a partial tariff deal with the UK, but most British goods will still be subject to a 10 per cent tariff when selling to US markets, raising the average US tariff rate from about 1 per cent last year to more than 6 per cent. The European Union is also in talks with the White House about avoiding a potential 55 per cent tariff on all its goods exports. • Britain's exporters at a loss over US tariff turmoil The debate over contractual terms between suppliers and customers is part of a swathe of legal complexities about who should shoulder the cost of import taxes. In April, Howmet Aerospace, an American supplier of components to the sector, declared a force majeure event that would allow it to stop shipments if it remained subject to US tariffs. Although the full gamut of threatened tariffs has not yet been applied on most countries, recent data has shown a spike in invoice rejections as businesses attempt to delay supplier payments until they have more certainty about US trade policy. Icertis's survey, which included 1,000 companies across Britain, the United States and India, found that just under half of them were 're-evaluating' where to find suppliers to avoid tariffs, restructuring their supply chains and manufacturing plants, and also considering 'sunsetting relationships that no longer serve under new cost and compliance pressures'. About 40 per cent of UK firms said they would absorb higher costs into their margins and just over a third said they were planning to raise prices charged to consumers to deal with tariffs. Bulacan said companies should also consider price adjustment clauses that account for tariff changes. 'In the same way that force majeure clauses changed fundamentally during the pandemic, these clauses could be invoked against new tariffs to prevent potential losses,' she said.
Times
39 minutes ago
- Times
High earners face surge in tax investigations
High earners face a surge in tax investigations after HM Revenue & Customs doubled revenues from inquiries into the wealthiest Britons last year. A freedom of information request has revealed that HMRC's wealthy and mid-sized business compliance directorate, which examines the tax affairs of those earning more than £200,000 a year or with assets above £2 million, yielded more than £1.5 billion in 2024, double the amount raised the previous year. The success of the unit has led to a decision to hire an extra 400 specialist compliance officers, who will be added over the next four years. The government hopes the move will bring in at least another £500 million in tax revenues by 2030. Accountants have said the number of investigations into wealthy individuals will inevitably increase.
